The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Minimisation assures similar distribution of selected participant factors between study groups.333 338”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [333]
Citations
Cites
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Residuals and Influence in Regression
Ling, R. F., Cook, R. D., & Weisberg, S. (1984) · Technometrics · doi:10.2307/1269506 · Cited by 2,875
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
Allocation concealment in randomised trials: defending against deciphering
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07750-4 · Cited by 923
Hunt, D. U., Varigos, G., Dienstl, F., Lechleitner, P., DeBacker, G., Kornitzer, M., Cairns, J., Turpie, A. G. G., Fritz-Hansen, P., Skagen, K., et al. (1992) · The Lancet · Cited by 894
Minimization: A new method of assigning patients to treatment and control groups
Taves, D. R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974155443 · Cited by 891
Forcing a sequential experiment to be balanced
EFRON, B. (1971) · Biometrika · doi:10.1093/biomet/58.3.403 · Cited by 873
Research works printed but not linked: 11
- International Conference un Harmonisation. Guidance on Statistical Principles Tor Clinical Trials. Federal Register. International Confer-ence on Harmonisation; E-9 Document. 1998: Vol.63, 179:49583–49598.
- Atkinson A. Beyond the platinum standard; ran-domisation and balancing covartales in sequential multi-center trials. Henry Stewart Conference on Statistics of Multi-center Trials. January 25, 2002. London.
- Cox DR. Randomization and concomitant variables in the design of experinents. In: Kallianpur G, Krishnaiah PR, Ghosh JK eds. Statistics and Probability: Essaya in Honor of Rao CR. Amsterdam, Holland: North Holland Publishing Company: 1982:197–202.
- ISIS-4 Collaborative Group. 1S1S-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 subjects with suspected myocardial infarction. Lancet. 1995:349:1413–1421.
- Reed JV, Wickham EA. Practical experience of minimization in clinical trials. Pharmaceut Med. 1988:3:349–359.
- Quinaux E, Buyse M, Choosing an optimal treatment allocation method in randomised clinical trials (poster). Presented at the Drug Information Association Annual Meeting. Chicago, IL, 2001.
- Ebbutt A, Kay R, McNamara J, Engler J, The analy-sis of trials using a minimization algorithm. In: 20th Anniversary Conference Report. Macclesfield, England: PSI; 1998:12–14.
- Dowlman N. Intelligent medication manage-ment—using IVR to optimise the drug supply process, Pharma Manufactur Pack Sourcer. 2001:Summer;24–28.
- Dowlman N. The cost benefits of using 1VR sys-tems in the supply chain. Pharma Manufactur Pack Sourcer. 2001;Autumn:74–79.
- Byrom B. Using IVRS in clinical trial management. Appl Clin Trials. 2002:10:36–42.
- Food and Drug Adminstration. 21 CFR Part 11. Electronic Records; Electronic Signatures. Federal Register. 1997; Vol. 62. 54:13430–13466.
Cited by
Sorted by citations
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
Castro, M., Rubin, A. S., Laviolette, M., Fiterman, J., Lima, M. D. A., Shah, P. L., Fiss, E., Olivenstein, R., Thomson, N. C., Niven, R. M., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0354oc · Cited by 670
Issues in Outcomes Research: An Overview of Randomization Techniques for Clinical Trials
Kang, M., Ragan, B. G., & Park, J.-H. (2008) · Journal of Athletic Training · doi:10.4085/1062-6050-43.2.215 · Cited by 555
Walker, I., Panzarella, T., Couban, S., Couture, F., Devins, G. M., Elemary, M., Gallagher, G., Kerr, H. M., Kuruvilla, J. G., Lee, S. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00462-3 · Cited by 365
Metadata
- Authors
- McEntegart, D. J.
- Corresponding author
- McEntegart, Damian J.
- Venue
- Drug Information Journal
- Published
- 2003-07
- Volume
- 37
- Issue
- 3
- Pages
- 293-308
- ISSN
- 0092-8615 (ISSN-L)
- 2164-9200
- OpenAlex
- W2011792098
- Cited by
- 145
- References
- 49
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 2 · 2019: 3 · 2018: 1 · 2016: 7 · 2015: 8 · 2014: 13 · 2013: 12 · 2012: 17
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Drug Information Journal (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- stratified randomization, prognostic factors, statistical efficiency, minimization, optimal allocation, drug supply
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
